The mouse data has shown an impressive combined impact on survival that is not reported in earlier literature suggesting that blocking NFATc3 could be an effective adjunctive treatment for severe sepsis that would prevent the development of the acute respiratory distress syndrome (ARDS) and improve patient survival. The gene discussed is NFATC3; the disease is Sepsis.